Cumberland Pharmaceuticals (CPIX) Other Non-Current Assets (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Other Non-Current Assets across 17 years of filings, most recently posting $2.9 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.9 million, up 6.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (up 6.71% YoY), and the FY2025 annual result was $3.0 million, up 6.8% from the prior year.
• Other Non-Current Assets came in at $2.9 million for Q1 2026 at Cumberland Pharmaceuticals, down from $3.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.2 million in Q1 2022 to a low of $2.4 million in Q3 2022.
• The 5-year median for Other Non-Current Assets is $2.8 million (2024), against an average of $2.8 million.
• Across the five-year window, Other Non-Current Assets slipped 27.34% in 2022 and grew 20.24% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Other Non-Current Assets stood at $2.5 million in 2022, then climbed by 6.83% to $2.7 million in 2023, then advanced by 3.38% to $2.8 million in 2024, then advanced by 6.8% to $3.0 million in 2025, then decreased by 1.59% to $2.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.